Current and emerging biologic therapies targeting eosinophilic disorders
Eosinophilic disorders include a wide array of conditions in which eosinophils play a primary pathophysiologic role.While historically treated with corticosteroids and immunosuppressants, knowledge of eosinophil biology has led to the development of several biologics targeting eosinophils.In this review, we discuss the current US Food and Drug Admi